Sr. Finance Manager, Commercial Finance Decision Support @ (October 2011 - May 2014)
Finance Manager, Commercial Finance Decision Support @ (January 2010 - October 2011)
Chief Financial Officer @ (July 2016 - April 2021)
Head of R and D Finance @ (October 2006 - January 2010)
Financial Analyst, FP and A @ CV Therapeutics (Acquired by Gilead) (September 2005 - October 2006)
Strategic Sourcing Manager @ (February 2002 - September 2005)
Cost Accountant, Brita FP and A @ (July 2001 - December 2001)
Anup Radhakrishnan Education
University of San Francisco
Bachelors (Finance)
1997-2001
Anup Radhakrishnan Skills
Accounting
Biotechnology
Business Development
Clinical Development
Clinical Trials
Cross-functional Team Leadership
Drug Development
Due Diligence
Finance
Financial Analysis
Immunology
Life Sciences
Long Range Planning
Management
Neurology
Oncology
Pharmaceutical Industry
Process Improvement
Product Launch
Rare Diseases
Strategy
Leadership
Strategic Planning
Cross Functional Team Leadership
Microsoft Office
Business Strategy
Customer Service
Microsoft Excel
Public Speaking
Anup Radhakrishnan Summary
Anup Radhakrishnan, based in California, United States, is currently a Interim Chief Executive Officer at CARGO Therapeutics. Anup Radhakrishnan brings experience from previous roles at CARGO Therapeutics and Dascena (Acquired, now DBA CirrusDx). Anup Radhakrishnan holds a 1997 - 2001 Bachelors in Finance @ University of San Francisco. With a robust skill set that includes Accounting, Biotechnology, Business Development, Clinical Development, Clinical Trials and more. Anup Radhakrishnan has 1 emails and 1 mobile phone numbers on RocketReach.
Looking for a different Anup Radhakrishnan?
Find contact details for 700 million professionals.